Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent Influenza Virus Vaccine”

243 trials

Showing 20 of 243 results

Large-scale testing (Phase 3)Study completedNCT02545543
What this trial is testing

Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age

Who this might be right for
Influenza, Human
Seqirus 2,278
Testing effectiveness (Phase 2)Ended earlyNCT01195779
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 4
Early research (Phase 1)Study completedNCT04439695
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults

Who this might be right for
Influenza
KBio Inc 120
Early research (Phase 1)Active Not RecruitingNCT07421037
What this trial is testing

Clinical Trial of Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older

Who this might be right for
InfluenzaInfluenza Vaccine
Ab&B Bio-tech Co., Ltd.JS 80
Large-scale testing (Phase 3)Study completedNCT02914275
What this trial is testing

Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.

Who this might be right for
Influenza, Human
Seqirus 2,250
Large-scale testing (Phase 3)WithdrawnNCT01810731
What this trial is testing

Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

Who this might be right for
Influenza, HumanHIVMalaria+2 more
Centers for Disease Control and Prevention
Post-approval studies (Phase 4)WithdrawnNCT03884296
What this trial is testing

Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood

Who this might be right for
Influenza
Stanford University
Testing effectiveness (Phase 2)UnknownNCT02434276
What this trial is testing

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

Who this might be right for
Influenza
VaxInnate Corporation 450
Large-scale testing (Phase 3)Study completedNCT01992107
What this trial is testing

Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old

Who this might be right for
Influenza
Novartis Vaccines 2,333
Testing effectiveness (Phase 2)Looking for participantsNCT06824519
What this trial is testing

Clinical Trials of Quadrivalent Influenza Vaccine

Who this might be right for
Influenza, Human
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 620
Post-approval studies (Phase 4)Study completedNCT06024096
What this trial is testing

Systems Biological Assessment of Statin Effect on Vaccine Responses

Who this might be right for
Vaccine Response
Emory University 63
Large-scale testing (Phase 3)Study completedNCT06385821
What this trial is testing

Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Who this might be right for
InfluenzaInfluenza AInfluenza, Human+8 more
NPO Petrovax 824
Large-scale testing (Phase 3)UnknownNCT02806804
What this trial is testing

Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60

Who this might be right for
Quadrivalent Influenza Virus Vaccine
Beijing Chaoyang District Centre for Disease Control and Prevention 2,400
Post-approval studies (Phase 4)Study completedNCT04109222
What this trial is testing

Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 90
Post-approval studies (Phase 4)Study completedNCT04551677
What this trial is testing

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 90
Not applicableStudy completedNCT05078060
What this trial is testing

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22

Who this might be right for
Influenza (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 1,804
Large-scale testing (Phase 3)Study completedNCT03704740
What this trial is testing

Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months

Who this might be right for
Influenza
SK Bioscience Co., Ltd. 676
Large-scale testing (Phase 3)Study completedNCT01240746
What this trial is testing

Study of Quadrivalent Influenza Vaccine Among Children

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 4,363
Post-approval studies (Phase 4)Study completedNCT02967393
What this trial is testing

Influenza Vaccine Feasibility Study in Children With Persistent Asthma

Who this might be right for
Asthmatic
Vanderbilt University Medical Center 40
Post-approval studies (Phase 4)Study completedNCT04559204
What this trial is testing

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

Who this might be right for
Influenza, HumanPneumonia, Pneumococcal
China National Biotec Group Company Limited 1,224
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation